Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial A Musa, E Khalil, A Hailu, J Olobo, M Balasegaram, R Omollo, T Edwards, ... PLoS neglected tropical diseases 6 (6), e1674, 2012 | 179 | 2012 |
Cutaneous leishmaniasis in Saudi Arabia: a comprehensive overview AA Abuzaid, AM Abdoon, MA Aldahan, AG Alzahrani, RF Alhakeem, ... Vector-Borne and Zoonotic Diseases 17 (10), 673-684, 2017 | 85 | 2017 |
Safety and efficacy of single dose versus multiple doses of AmBisome® for treatment of visceral leishmaniasis in eastern Africa: a randomised trial EAG Khalil, T Weldegebreal, BM Younis, R Omollo, AM Musa, W Hailu, ... PLoS neglected tropical diseases 8 (1), e2613, 2014 | 85 | 2014 |
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East … R Omollo, N Alexander, T Edwards, EAG Khalil, BM Younis, AA Abuzaid, ... Trials 12, 1-10, 2011 | 68 | 2011 |
The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs F Meheus, AA Abuzaid, R Baltussen, BM Younis, M Balasegaram, ... The American Journal of Tropical Medicine and Hygiene 89 (6), 1146, 2013 | 50 | 2013 |
Treatment-based strategy for the management of post-kala-azar dermal leishmaniasis patients in the Sudan AM Musa, EAG Khalil, BM Younis, MEE Elfaki, MY Elamin, AOA Adam, ... Journal of tropical medicine 2013, 2013 | 25 | 2013 |
Visceral leishmaniasis in Saudi Arabia: From hundreds of cases to zero AA Abuzaid, MA Aldahan, MA Al Helal, AM Assiri, MH Alzahrani Acta tropica 212, 105707, 2020 | 11 | 2020 |
Lack of zika virus and other recognized flaviviruses among the mosquito vectors during and post the hajj mass gathering S Yezli, M Yasir, Y Yassin, A Almazrua, T Al-Subhi, N Othman, A Omar, ... International Journal of Environmental Research and Public Health 18 (12), 6275, 2021 | 3 | 2021 |
Isolation and deisolation of patients admitted with presumptive pulmonary tuberculosis: Can it be shortened? FE Elzein, N Alsherbeeni, M Mursi, SF Algoblan, AA Abuzaid, ... Saudi Medical Journal 40 (10), 1008, 2019 | 2 | 2019 |
AmBisome® for visceral leishmaniasis patients in East Africa: a multi-centre randomized trial EA Khalil, T Weldegebreal, B Younis, Z Hurissa, W Hailu, AA Abuzaid, ... Clinical pharmacology in leishmaniasis: treatment optimization of a …, 2012 | | 2012 |
HEPATOTOXIC EFFECTS OF VISCERAL LESHMANIASIS: CYTOCHROME C AS A MARKER OF HEPATOCYTES APOPTOSIS WEM Eltayeb, AM Musa, BM Younis, AA Abuzaid, AM Elhassan CLINICAL CHEMISTRY AND LABORATORY MEDICINE 49, S520-S520, 2011 | | 2011 |